GlassScriptPhysician profile
Jimmy Johannes
NPI 1275837205
$8,046.40
in general payments reported to CMS, 2019-2025
45 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $884 · 2021: $836 · 2022: $1,433 · 2023: $1,942 · 2024: $526 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Travel and Lodging: $1,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.03 |
| Travel and Lodging | $1,900.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $2,170.14 | 2023-2025 | Galaxy |
| Glaxosmithkline, LLC. | $1,164.86 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $575.52 | 2019-2025 | Tagrisso, Breztri, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.43 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $509.09 | 2021-2023 | Dupixent |
| Vertex Pharmaceuticals Incorporated | $436.67 | 2019-2025 | |
| Inspire Medical Systems, INC. | $265.06 | 2024-2025 | Inspire |
| Intuitive Surgical, INC. | $258.30 | 2022-2024 | |
| Amgen INC. | $248.38 | 2019-2025 | Tezspire |
| Inari Medical, INC. | $141.99 | 2019 | |
| Vapotherm INC | $139.17 | 2022 | |
| Insmed, INC. | $138.22 | 2020-2021 | |
| La Jolla Pharmaceutical Company | $135.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $131.65 | 2020-2021 | |
| Ethicon INC. | $119.88 | 2022 |
Show all 43 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Johannes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.